Estrogen replacement therapy and the mixed lymphocyte reaction
- 1 October 1981
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 141 (4) , 393-397
- https://doi.org/10.1016/0002-9378(81)90600-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Characterization of the estrogen receptors in the uterine and blood eosinophil leukocytesCellular and Molecular Life Sciences, 1976
- A radioimmunoassay for “the pregnancy zone protein”Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- HORMONAL CONTRACEPTION OR THERAPY AND ALTERED IMMUNITYThe Lancet, 1975
- CORTISOL METABOLISM AFTER ORAL CONTRACEPTIVES: TOTAL PLASMA CORTISOL AND THE FREE CORTISOL INDEXBJOG: An International Journal of Obstetrics and Gynaecology, 1975
- Inhibition of the mixed lymphocyte reaction by the pregnancy zone proteinFEBS Letters, 1975
- PHYTOHÆMAGGLUTININ-INDUCED LYMPHOCYTE TRANSFORMATION AND CIRCULATING AUTOANTIBODIES IN WOMEN TAKING ORAL CONTRACEPTIVESThe Lancet, 1974
- Is Cortisol Responsible for Inhibition of MLC Reactions by Pregnancy Plasma?Nature, 1973
- Depression of Cellular Immunity in Pregnancy due to a Serum FactorBMJ, 1973
- DEPRESSED LYMPHOCYTE RESPONSE TO P.H.A. IN WOMEN TAKING ORAL CONTRACEPTIVESThe Lancet, 1972
- DEPRESSED MATERNAL LYMPHOCYTE RESPONSE TO PHYTOHÆMAGGLUTININ IN HUMAN PREGNANCYThe Lancet, 1972